Fosun International’s Bristol-Myers Squibb BMY Stock Holding History

Fosun International’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-83,000	Closed	-$3.74M	–	247
2019 Q2	$3.74M	Hold	83,000	–	–	0.25%	62
2019 Q1	$3.97M	Buy	+83,000	New	+$4.13M	0.25%	57

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fosun International's BMY Position: Q3 2019 in Review

Fosun International sold out of Bristol-Myers Squibb (BMY) in Q3 2019, closing a stake of 83,000 shares — an estimated $3.74M sold.

Fosun International first reported a position in BMY in Q1 2019 and held it in 2 quarters. The position peaked at $3.97M in Q1 2019. 1,813 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

Fosun International reported no remaining Bristol-Myers Squibb position as of Q3 2019 after selling out during the quarter.
Fosun International sold 83,000 Bristol-Myers Squibb shares in Q3 2019, an estimated $3.74M.
Fosun International first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 2 quarters.
Fosun International's Bristol-Myers Squibb position peaked at $3.97M in Q1 2019.
1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.